Metformin limits osteoarthritis development and progression through activation of AMPK signalling

J Li, B Zhang, WX Liu, K Lu, H Pan, T Wang… - Annals of the …, 2020 - ard.bmj.com
Objectives In this study, we aim to determine the effect of metformin on osteoarthritis (OA)
development and progression. Methods Destabilisation of the medial meniscus (DMM) …

[HTML][HTML] Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior

H Li, X Ding, R Terkeltaub, H Lin, Y Zhang… - Arthritis Research & …, 2020 - Springer
Background Metformin could activate adenosine monophosphate-activated protein kinase
(AMPK) which was postulated as a potential therapeutic target for osteoarthritis. This study …

[HTML][HTML] Metformin attenuates cartilage degeneration in an experimental osteoarthritis model by regulating AMPK/mTOR

X Feng, J Pan, J Li, C Zeng, W Qi, Y Shao, X Liu… - Aging (albany …, 2020 - ncbi.nlm.nih.gov
Background: It is generally thought that the occurrence and progression of osteoarthritis
(OA) results from multiple causes, including degradation and destruction of the cartilage …

[HTML][HTML] Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway

H Guo, D Ding, L Wang, J Yan, L Ma, Q Jin - PLoS One, 2021 - journals.plos.org
This study explored the mechanism by which metformin (Met) inhibits osteoclast activation
and determined its effects on osteoarthritis (OA) mice. Bone marrow-derived macrophages …

Peroxisome proliferator–activated receptor γ coactivator 1α and FoxO3A mediate chondroprotection by AMP‐activated protein kinase

X Zhao, F Petursson, B Viollet, M Lotz… - Arthritis & …, 2014 - Wiley Online Library
Objective AMP‐activated protein kinase (AMPK) inhibits chondrocyte procatabolic
responses to inflammation and biomechanical injury. This study was undertaken to test the …

[HTML][HTML] Linked decreases in liver kinase B1 and AMP-activated protein kinase activity modulate matrix catabolic responses to biomechanical injury in chondrocytes

F Petursson, M Husa, R June, M Lotz… - Arthritis research & …, 2013 - Springer
Introduction AMP-activated protein kinase (AMPK) maintains cultured chondrocyte matrix
homeostasis in response to inflammatory cytokines. AMPK activity is decreased in human …

Chondrocyte AMP‐activated protein kinase activity suppresses matrix degradation responses to proinflammatory cytokines interleukin‐1β and tumor necrosis factor α

R Terkeltaub, B Yang, M Lotz… - Arthritis & …, 2011 - Wiley Online Library
Abstract Objective Interleukin‐1β (IL‐1β) and tumor necrosis factor α (TNFα) stimulate
chondrocyte matrix catabolic responses, thereby compromising cartilage homeostasis in …

[HTML][HTML] Metformin: a potential therapeutic tool for rheumatologists

T Salvatore, PC Pafundi, R Galiero, K Gjeloshi… - Pharmaceuticals, 2020 - mdpi.com
Metformin is an oral antihyperglycemic drug widely used to treat type 2 diabetes, acting via
indirect activation of 5′ Adenosine Monophosphate-activated Protein Kinase (AMPK) …

[HTML][HTML] Metformin attenuates monosodium-iodoacetate-induced osteoarthritis via regulation of pain mediators and the autophagy–lysosomal pathway

HS Na, JY Kwon, SY Lee, SH Lee, AR Lee, JS Woo… - Cells, 2021 - mdpi.com
Osteoarthritis (OA) is the most common degenerative arthritis associated with pain and
cartilage destruction in the elderly; it is known to be involved in inflammation as well. A drug …

[HTML][HTML] AMPK deficiency in chondrocytes accelerated the progression of instability-induced and ageing-associated osteoarthritis in adult mice

S Zhou, W Lu, L Chen, Q Ge, D Chen, Z Xu, D Shi… - Scientific Reports, 2017 - nature.com
Osteoarthritis (OA) is a progressive degenerative disease of the joints that is associated with
both joint injury and ageing. Here, we investigated the role of the energy sensor AMP …